North America

Accenture Plc to acquire rival Booz & Co

Management consulting firm Accenture Plc announced that they are moving towards a possible acquisition of rival Booz & Company.


Kontextual raises up to US$650,000 in its seed funding

Kontextual announced that, with the latest investments coming from RPM Ventures, they have raised up to US$650,000 for their seed fund.

Jifiti raises US$2.5 million from institutional investors

Jifiti announced that it had collect US$2.5 million from institutional investors in an investment round.

Microsoft admits losing money due to Surface tablets

Microsoft Corp. specified that the Surface tablets were the reason its total production expenses increased.


Latest News

E2open inks the US$34 million deal for the acquisition of icon-scm. E2open announced that they have acquired icon-scm in a transaction that was valued at US$34 million.
Private equity firm, Blackstone Group announced that they are planning to acquire seven properties from GE Capital Real Estate worth AUD290 million.
America Homes 4 Rent have set prices for their impending public offering. American Homes 4 Rent said that they are targeting prices between US$16 to US$18 per share for the company's initial public offering.
Sources said EIV Capital Management Company had now raised US$65 million for its new energy investment fund.
Sithe Global Power announced that Bruce J. Wrobel chief executive officer and chairman is stepping down and that Martin B. Rosenberg and Brian H. Kubeck are to succeed him.
Famous hedge fund investor criticized Sony's entertainment division as part of his ongoing campaign to create a spin-off.
Norwegian Cruise Lines' investors TPG Capital, Apollo Global Management LLC and Genting Hong Kong Ltd are set to sell US$600 million worth of holdings.
Cubist Pharmaceuticals widens antibiotics portfolio with the Optimer Pharmaceuticals Inc and Trius Therapeutics Inc acquisition.
Kinetic Concepts Inc. revealed that they had signed an investment agreement to acquire Systagenix for US$485 million.
MVC Capital revealed that it had committed to issuing Biogenic Reagents a senior secured convertible note worth US$9.5 million with a five year maturity.